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Abstract
Background: There are no easily available markers of renal recovery to guide intermittent hemodialysis (IHD) weaning.
The aim of this study was to identify markers for IHD weaning in critically ill patients with acute kidney injury (AKI).
Methods: We performed a retrospective single-center cohort study of patients treated with IHD for at least 7 days and
four dialysis sessions for AKI between 2006 and 2011 in an intensive care unit (ICU) of a French university hospital.
Blood and urinary markers were recorded on the day of the last IHD in the ICU for unweaned patients and 2 days after
the last IHD for weaned patients. Factors associated with IHD weaning were identified by multiple logistic regression.
The areas under the receiver operating characteristic curve (AUROC) and the characteristics of the best diagnostic
thresholds were compared.
Results: Sixty-seven patients were analyzed, including thirty-seven IHD-weaned patients. Urine output [odds ratio (OR)
1.59, 95 % confidence interval (CI) 1.20–2.10 (per ml/kg/24 h increase); P = 0.01] and urinary urea concentration [OR
1.29, 95 % CI 1.01–1.64 (per 10 mmol/L increase); P = 0.04] were both associated with IHD weaning. The optimal
diagnostic thresholds for IHD weaning were urine output greater than 8.5 ml/kg/24 h, urinary urea concentration
greater than 148 mmol/L, and daily urea excretion greater than 1.35 mmol/kg/24 h, with accuracy of 82.1 %, 76.1 %,
and 92.5 % (P = 0.03), respectively. The AUROC of daily urinary urea excretion (0.96) was greater than the AUROC of
urine output (0.86) or the AUROC of urinary urea concentration (0.83) (P < 0.001).
Conclusions: A daily urinary urea excretion greater than 1.35 mmol/kg/24 h was found to be the best marker for
weaning ICU patients with AKI from IHD.
Keywords: Acute kidney injury, Renal replacement therapy, Intermittent hemodialysis, Weaning, Critical illness,
Intensive care
Background
In intensive care units (ICUs), renal replacement therapy
(RRT) for acute kidney injury (AKI) increases the risk of
bleeding, hemodynamic instability, underdosage of anti-
biotics, nutrient loss, and infections [1–5]. These com-
plications increase with the length of RRT and lead to
increased mortality and decreased likelihood of renal
recovery [6]. Improving RRT modalities has had a posi-
tive effect on the outcomes of ICU patients with AKI
[7–11]. The length of RRT has an impact on mortality
and renal recovery [12]. Most studies have focused on the
timing of RRT initiation [13–15], and very few have
assessed the criteria for RRT weaning. Although re-
searchers in one study reported that creatinine clearance
could help in making decisions about when to discontinue
continuous RRT, serum creatinine decreases during con-
tinuous RRT and therefore is not a relevant factor for
weaning [16]. Studies have shown that an increase in urine
output can be used as a marker for RRT weaning [17, 18].
The main limitations of this marker for predicting
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successful RRT weaning are the potential preservation of
urine output during renal failure, the occurrence of urine
output before renal recovery, and the negative impact of
diuretic use on its predictive ability [17]. Renal function
can be assessed not only by urine output but also by the
urinary concentration of the waste products of metabol-
ism as measured by urinalysis. We hypothesized that the
increase in urine concentration could be a marker of renal
function recovery in patients with AKI requiring RRT.
Intermittent hemodialysis (IHD) is widely used in RRT
weaning because it is less expensive, decreases the risk of
catheter infection, and allows early mobilization of the pa-
tient, which improves outcomes [19–21]. The aim of the
present study was to identify markers in urinalysis for
IHD weaning in critically ill patients with AKI.
Methods
Setting and study population
We conducted a retrospective single-center cohort study
in a ten-bed medical ICU of a university hospital in
France. This study was approved by our institutional re-
view board (CPP Sud-Est 6 – IRB00008526 number 2015/
CE90) in accordance with French regulations. The board
waived the need for signed informed consent for patients
included. All consecutive patients with AKI requiring RRT
between January 2006 and December 2011 were screened.
The inclusion criteria were patients with AKI older than
18 years treated with IHD for at least 7 days and four IHD
sessions. The exclusion criteria were patients with a deci-
sion to forgo life-sustaining treatment, patients who had
undergone renal transplantation, patients treated with
continuous RRT at the time of weaning, chronic dialysis
patients, and patients with urine output less than 100 ml/
24 h before the last dialysis session in the ICU.
Renal replacement therapy
The criteria for initiation of RRT for AKI were at the
discretion of the physician. The determinants usually
used for initiation of RRT in our ICU were serum urea
concentration greater than 25 mmol/L, serum potassium
concentration greater than 6 mmol/L, metabolic acidosis
with pH less than 7.15, and acute pulmonary edema due to
fluid overload with diuretic resistance. Patients who re-
quired RRT were treated with IHD, in some cases preceded
by continuous RRT. IHD was promoted when the meta-
bolic disorders were severe. Continuous RRT was pro-
moted when fluid overloading was very high. IHD sessions
were performed with the AK 200 Ultra S machine
(Gambro, Meyzieu, France) and APS (Asahi PolySulfone)
biocompatible dialysis membranes (Hemotech, Ramonville
Saint-Agne, France). Anticoagulation was achieved with
unfractionated heparin or low molecular weight heparin.
Continuous RRT was performed with predilution hemofil-
tration or postdilution hemodiafiltration (ratio of dialysate
to postdilution effluent equal to 1:1). Anticoagulation of
continuous RRT was achieved with unfractionated heparin.
Vascular access was a temporary double-lumen dialysis
catheter positioned in a femoral or internal jugular vein.
No protocol was used to make the decision to cease
hemodialysis treatment.
Data collection
Data were collected from consulting patients’ medical re-
cords and the electronic databases of the ICU and the De-
partment of Medical Biochemistry at our institution. They
comprised baseline demographic characteristics, type of ad-
mission, severity of illness and comorbidity score, amine and
mechanical ventilation use, baseline serum creatinine, start-
ing and cessation dates of RRT in the ICU, weaning date in
the ICU, and diuretic use. Baseline serum creatinine was de-
fined as the lowest serum creatinine value in the year before
RRT initiation. Baseline glomerular filtration rate (GFR) was
estimated according to the Modified Diet in Renal Disease
equation [22]. Severity of illness at ICU admission was
assessed on the basis of the Simplified Acute Physiology
Score II and Sequential Organ Failure Assessment (SOFA)
score. Comorbidities were evaluated by McCabe score.
Serum electrolyte, creatinine, and urea concentrations were
measured daily at 0700 h. In addition, 24-h urine output
values (from 0700 to 0700 h) were collected daily. Con-
centrations of electrolytes, creatinine, and urea from 24-h
urine collections were measured at 0700 h. Daily urinary
urea excretion was defined as the product of urine output
over 24 h and urinary urea concentration. Urine output
was adjusted for the patient’s body weight at ICU admis-
sion. A patient was considered weaned in the ICU when
dialysis was stopped for at least 1 week. For weaned pa-
tients, concentrations of electrolytes, creatinine, and urea
in the blood and urine and 24-h urine output values were
recorded 2 days after the last dialysis session. This day was
chosen because it is the moment at which the decision to
stop or to continue IHD is usually made. For unweaned
patients, the same data were collected on the day of the
last dialysis session in the ICU. One month after ICU dis-
charge, renal outcome was recorded. Renal outcome could
be either chronic RRT or renal recovery. Renal recovery
was complete if serum creatinine was less than 125 % of
baseline creatinine and partial otherwise [23].
Statistical analysis
Statistical analysis was performed with Stata 13 software
(StataCorp, College Station, TX, USA). The tests were
two-sided, with a type I error set at α = 0.05. Variables
were presented as medians (interquartile range) for con-
tinuous data and as the number of patients and associated
percentages for categorical parameters. Comparisons be-
tween the weaned and unweaned groups were made by
using χ2 or Fisher’s exact tests for categorical variables and
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Student’s t test or the Mann–Whitney U test for quantita-
tive parameters. Assumption of normality was assessed by
using the Shapiro–Wilk test, and homoscedasticity was
verified by using the Fisher-Snedecor test. To identify
independent predictors of IHD weaning, a multivariate
logistic regression analysis was performed with IHD
weaning as the dependent variable. The interactions be-
tween factors were tested. All variables whose values
were significantly different between the two groups
were included. The predictive ability of urine output,
urinary urea concentration, and daily urinary urea ex-
cretion was assessed with the area under the receiver
operating characteristic curve (AUROC) method. Opti-
mal diagnostic thresholds were determined by Youden’s
index [1 − (sensitivity + specificity)]. AUROC curves
were compared by using the DeLong method [24]. The
sensibility, specificity, and accuracy (percentage of pa-
tients correctly classified in the weaned or unweaned
groups) were compared by using Cochran’s Q test.
Positive and negative predictive values were compared
by using Fisher’s exact test.
Results
Patient characteristics
During the 6-year study period, 144 patients treated with
IHD for AKI were identified (Fig. 1). Of these, 56 were
excluded because of a decision to forgo life-sustaining
therapy (n = 46) renal transplantation (n = 7), or continu-
ous RRT at the time of weaning (n = 3). Another 21 were
excluded for urine output less than 100 ml/24 h. Thus,
67 patients were finally analyzed, 37 of whom were
weaned and 30 of whom were unweaned. Of the 37
weaned patients, none had to restart RRT in the months
following RRT weaning. All 30 unweaned patients had
dialysis sessions after ICU discharge, but only 4 subse-
quently recovered renal function and were able to stop
RRT a median of 7 (3–8) days after ICU discharge.
The patients’ characteristics are given in Table 1.
Weaned patients had chronic kidney failure less fre-
quently and required vasoactive drugs more frequently.
In weaned patients, no difference was observed in urine
output with or without diuretic use [15.4 (11.2–22.0) vs.
13.3 (9.4–24.2) ml/kg/24 h, P = 0.70]. Variables related to
RRT during the ICU stay are shown in Table 2.
Identification of weaning markers
The variables that differed significantly between un-
weaned and weaned patients were serum creatinine
concentration [median 386 (interquartile range 317–468)
vs. 253 (191–325) μmol/L, P < 0.001], urinary urea
concentration [92 (67–123) vs. 160 (124–222) mmol/L,
P < 0.001], urine osmolality [289 (263–306) vs. 345
Fig. 1 Patient flowchart. AKI acute kidney injury, CRRT continuous renal replacement therapy, DFLST decision to forgo life-sustaining therapy, IHD
intermittent hemodialysis, ICU intensive care unit, RRT renal replacement therapy, UO urine output
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(302–375) mmol/L, P = 0.01], and urine output [6.5
(4.0–9.2) vs. 14.5 (9.6–22.4) ml/kg/24 h, P < 0.001].
No difference was observed in serum urea concentration
[20.4 (17.1–25.4) vs. 20.2 (15.9–25.9) mmol/L, P = 0.61]
and urinary creatinine concentration [4463 (3244–6396)
vs. 3922 (2893–6317) μmol/L, P = 0.85]. In a multivariate
logistic regression model (Table 3), independent predic-
tors for IHD weaning were 24-h urine output [odds ratio
1.59 per ml/kg/24 h increase, 95 % confidence interval
(CI) 1.20–2.10, P = 0.01] and urinary urea concentration
(odds ratio 1.29 per 10 mmol/L increase, 95 % CI
1.01–1.64, P = 0.04). These two independent predictors for
IHD weaning were also found when the urine output was
not adjusted for body weight (Additional file 1).
Predictive value of urine output, urinary urea
concentration and daily urea excretion
The AUROCs for predicting IHD weaning were 0.86
(95 % CI 0.79–0.94, P < 0.001) for urine output, 0.83
(95 % CI 0.74–0.92, P < 0.001) for urinary urea concen-
tration, and 0.96 (95 % CI 0.93–0.99, P < 0.001) for daily
urinary urea excretion (Fig. 2a). The AUROC of daily
urinary urea excretion was greater than that of urine out-
put (P = 0.02) and urinary urea concentration (P = 0.01).
The optimal thresholds for IHD weaning were urine out-
put greater than 8.5 ml/kg/24 h, urinary urea concentra-
tion greater than 148 mmol/L, and daily urinary urea
excretion greater than 1.35 mmol/kg/24 h. The sensitivity,
specificity, positive predictive value, negative predictive
Table 1 Baseline and clinical characteristics of study patients
Variables All patients (n = 67) Unweaned (n = 30) Weaned (n = 37) P value
Age, years 64 (52–73) 63 (47–67) 65 (55–73) 0.22
Male sex, n (%) 48 (71.6) 25 (83.3) 23 (62.1) 0.06
Admission type, n (%) 0.09
Medical 55 (82.1) 27 (90.0) 28 (75.7)
Unscheduled surgery 11 (16.4) 2 (6.6) 9 (24.3)
Scheduled surgery 1 (1.4) 1 (3.3) 0 (0)
BMI, kg/m2 26 (23–31) 25 (21–30) 28 (25–31) 0.22
SOFA score, points 9 (6–13) 9 (6–10) 11 (7–14) 0.07
SAPS2 score, points 61 (45–72) 58 (44–68) 64 (46–73) 0.37
McCabe score, n (%) 0.54
0 49 (73.1) 20 (66.7) 29 (78.7)
1 14 (20.9) 8 (26.7) 6 (16.2)
2 4 (5.9) 2 (6.7) 2 (5.4)
Baseline GFRa, n (%) <0.001
>90 ml/min/1.73 m2 13 (19.4) 2 (6.7) 11 (29.7)
60–90 ml/min/1.73 m2 16 (23.9) 4 (13.3) 12 (32.4)
30–60 ml/min/1.73 m2 16 (23.9) 7 (23.3) 9 (24.3)
15–30 ml/min/1.73 m2 16 (23.9) 11 (36.7) 5 (13.5)
<15 ml/min/1.73 m2 6 (9.0) 6 (20.0) 0 (0.0)
Contributing factors to AKI, n (%)
Ischemia 60 (89.6) 26 (86.6) 34 (91.8) 0.49
Nephrotoxicity 18 (26.8) 10 (33.3) 8 (24.3) 0.28
Sepsis 42 (62.7) 18 (60.0) 24 (64.8) 0.68
Other 9 (13.4) 4 (13.3) 5 (13.5) 0.98
Length of ICU stay, days 18 (10–31) 11 (7–15) 26 (17–42) 0.01
Renal replacement therapy, days 11 (7–15) 10 (7–15) 11 (8–15) 0.90
Diuretic at the last dialysis session, n (%) 7 (10.4) 1 (3.3) 6 (16.2) 0.09
Mechanical ventilation during ICU stay, n (%) 46 (68.7) 17 (56.7) 29 (78.3) 0.06
Amines during ICU stay, n (%) 47 (70.1) 15 (50.0) 32 (86.5) 0.01
AKI acute kidney injury, BMI body mass index, GFR glomerular filtration rate estimated using Modified Diet in Renal Disease equation, ICU intensive care unit, RRT
renal replacement therapy, SAPS2 Simplified Acute Physiological Score II, SOFA sequential organ failure assessment
Data are presented as median (interquartile range) or count (%)
aBaseline GFR classified according to Kidney Disease: Improving Global Outcomes classification
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value, and accuracy for each of these thresholds are shown
in Table 4. A daily urinary urea excretion greater than
1.35 mmol/kg/24 h provided better accuracy (92.5 %) than
a urine output greater than 8.5 ml/kg/24 h (82.1 %,
P = 0.03) or a urinary urea concentration greater) than
148 mmol/L (76.1 %, P = 0.01) (Table 3). The optimal
thresholds for urine output and daily urinary urea excre-
tion unadjusted for the body weight were 826 ml/24 h and
92 mmol/24 h, respectively (Additional file 2). The distri-
bution of weaned and unweaned patients according to
values of urine output, urinary urea concentration, and
daily urinary urea excretion is shown in Fig. 2b.
Discussion
The main result of this study was the determination of
thresholds of urine markers for IHD weaning in ICU pa-
tients with AKI. A daily urinary urea excretion greater
than 1.35 mmol/kg/24 h was the best marker of renal re-
covery for IHD weaning.
There is no specific recommendation regarding the
criteria for identifying patients who have recovered suffi-
cient renal function to allow RRT weaning. In major
randomized controlled trials on RRT [10, 11], the cri-
teria of RRT weaning were based on urine output
(greater than 400 ml/24 h), creatinine clearance (greater
than 20 ml/minute assessed using 6-h urine collection in
patients with urine output higher than 30 ml/h), or the
discretion of the physician. In an observational study of 94
patients with postoperative AKI, researchers reported that
longer duration of dialysis, age older than 65 years, higher
SOFA score, and urine output less than 100 ml/8 h were
associated with weaning failure [18]. In their study, the
urine output on the day following the last session was sig-
nificantly greater in weaned patients (1435 ml/24 h vs.
Table 2 Variables related to renal replacement therapy during the ICU stay
Variables All patients (n = 67) Unweaned (n = 30) Weaned (n = 37) P value
Duration of RRT, days 11 (7–15) 10 (7–15) 11 (8–15) 0.90
Patients treated with CRRT, n (%) 20 (30) 7 (23) 13 (35) 0.05
Duration of CRRT, days 5 (2–7) 3 (3–6.5) 5 (2–7) 0.90
Patients treated with hemofiltrationa, n (%) 9 (13) 3 (10) 6 (16) 0.46
Patients treated with hemodiafiltrationb, n (%) 11 (16) 4 (13) 7 (19) 0.54
Prescribed total effluent flow of CRRTc, ml/kg/day 45.7 (44.4–47.0) 42.8 (42.0–43.6) 46.5 (45.3–48.5) 0.23
Blood flow of CRRT, ml/minute 200 (200–200) 200 (200–200) 200 (200–200) 0.34
IHD sessions during ICU stay, n 7 (5–10) 7 (5–9) 7 (5–10) 0.47
Duration of IHD session, h 4.1 (3.7–4.6) 4.0 (3.8–4.5) 4.2 (3.5–4.6) 0.88
IHD sessions per week, n 5.5 (4.4–6.2) 5.0 (4.4–6.1) 5.8 (4.4–6.4) 0.29
Blood flow of IHD, ml/minute 214 (200–240) 233 (208–250) 209 (200–217) 0.01
Dialysate flow, ml/minute 540 (500–586) 530 (500–571) 545 (500–596) 0.52
K t/V/IHD sessiond 0.91 (0.73–1.09) 0.82 (0.71–1.08) 0.95 (0.76–1.09) 0.83
Net ultrafiltration, L/h 0.25 (0.18–0.38) 0.24 (0.18–0.38) 0.27 (0.18–0.38) 0.66
Percentage of IHD sessions with hypotensione 16.6 (0.00–25.0) 16.6 (0.00–24.0) 15.5 (0.00–27.7) 0.60
RRT renal replacement therapy, CRRT continuous renal replacement therapy, IHD intermittent hemodialysis
Data are presented as median (interquartile range) or count (%)
aAll hemofiltration was delivered with predilution mode
bAll hemodiafiltration was delivered with postdilution mode and a ratio of dialysate to postdilution effluent equal to 1:1
cFor hemodiafiltration, the total effluent was the sum of the dialysate and the postdilution effluent
dK t/V was measured with ionic dialysance
eHypotension requiring fluid challenge or increase of vasoactive drug
Table 3 Logistic regression model for predicting intermittent hemodialysis weaning
Univariate analysis Multivariate analysisa
Parameter OR 95 % CI P value OR 95 % CI P value
SCr, per 10 μmol/L 0.96 (0.88–0.96) <0.001 0.96 (0.90–1.03) 0.27
Uurea, per10 mmol/L 1.27 (1.12–1.44) <0.001 1.29 (1.01–1.64) 0.04
Uosm, per 10 mmol/L 1.15 (1.04–1.27) 0.01 1.17 (0.94–1.45) 0.16
UO, per ml/kg/24 h 1.33 (1.14–1.55) 0.01 1.59 (1.20–2.10) 0.01
SCr serum creatinine, OR, odds ratio, CI confidence interval, Uurea urinary urea concentration, UO urine output, Uosm urine osmolality
aAdjusted for diuretic use
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598 ml/24 h). In a post hoc analysis of 529 patients from
the BEST study, urine output was the main predictor of
successful RRT cessation [17]. In this analysis, the AUROC
of patients without diuretics was 0.845 and the best
threshold was 436 ml/24 h, but the AUROC decreased to
0.671 with the best threshold at 2330 ml/24 h in patients
with diuretics [17]. In our study, we determined one urine
output threshold, which was intermediate (8.5 ml/kg/24 h
or 826 ml/24 h), because 90 % of the patients received no
diuretics. However, the physiological data show that the
predictive ability of urine output for recovery of renal
function is poor. The two major determinants of urine
output are osmotic load, composed mainly of urea and so-
dium chloride delivery on the distal tubule, and urine con-
centration. Both these determinants are related to factors
other than the recovery of renal function. Osmotic load
results from several factors, including GFR, urea gener-
ation caused by protein catabolism, and variations in so-
dium reabsorption in response to circulating blood
volume or diuretic use [25]. Urine concentration results
from the functional integrity of the renal tubule [26] and
the release of arginine vasopressin [27].
Our study shows that daily urinary urea excretion has
a better predictive value than urine output or urinary
urea concentration alone for IHD weaning in ICU pa-
tients with AKI. Daily urinary urea excretion results
from the GFR, serum urea concentration, and urea tubu-
lar reabsorption. Urea is freely filtered across the glomeru-
lus, and 50 % is reabsorbed in the outer medulla and then
secreted in the inner medulla. This recycling of urea cre-
ates a concentration gradient in the medulla, which causes
the movement of electrolyte and water that leads to urine
formation [26]. Consequently, an increase in daily urinary
urea excretion requires the recovery of tubular cell integ-
rity and of urine concentration ability. These data suggest
that the daily urinary urea excretion is one of the first
markers of renal recovery after AKI requiring RRT.
The objective of our study was not to assess the fac-
tors that influence the renal recovery. However, we
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Fig. 2 a Predictive ability for intermittent hemodialysis weaning. The area under the receiver operating characteristic curve values were 0.86
(0.79–0.94) for UO, 0.83 (0.74–0.92) for uUrea, and 0.96 (0.93–0.99) for eUrea. Thresholds with the highest accuracy are given for each variable.
b Distribution of weaned and unweaned patients according to UO, uUrea, and eUrea. The blue curve corresponds to an eUrea of 1.35 mmol/kg/24 h
and was obtained using the following equation: [UO (ml/kg/24 h)/1000] × uUrea (mmol/L) = 1.35 mmol/kg/24 h. eUrea daily urinary urea excretion,
uUrea urinary urea concentration, UO urine output
Table 4 Comparison of diagnostic values
Variables UO >8.6 ml/kg/24 h Uurea >148 mmol/L eUrea >1.35 mmol/kg/24 h P value
Sen, % 89.2a 64.9a 89.2b 0.01
Spe, % 73.3a 90.0b 96.7b 0.01
PPV, % 80.5a 88.9b 97.1b 0.05
NPV, % 84.6 67.5 87.9 0.09
Accuracy, % 82.1a 76.1a 92.5b 0.03
eUrea daily urinary urea excretion, PPV positive predictive value, NPV negative predictive value, Sen sensitivity, Spe specificity, UO urine output, Uurea urinary
urea concentration
a,bValues are significantly different
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vasoactive drugs and that there was a trend toward
more continuous RRT in weaned patients than in un-
weaned patients (Table 2). Furthermore, there was no
difference between the patient groups in the percentage
of IHD with hypotension requiring fluid challenge or an
increase in vasoactive drug use. These data suggest an
association between weaned patients and continuous
RRT and are consistent with other results that show a
beneficial association between continuous RRT and
renal recovery [28–30].
Our study has a number of limitations. First, the study
design was retrospective. However, data analysis from
real clinical practice is the first step in finding new and
relevant markers. The collection of data was exhaustive,
with multiple screening of patients from several different
databases. Hence, the possibility of overlooking a patient
meeting the inclusion criteria was very low. Although
our data collection was exhaustive and the statistical
analysis robust, further prospective studies are needed to
assess whether our findings can be used to make clinical
decisions. Second, daily urinary urea excretion requires
accurate urine collection over 24 h. Urine collection and
urinalysis are easily done with urine catheters and are
routinely used in clinical practice in the ICU. In
addition, 24-h urine collection reduces biases of inaccur-
acy. Daily urinary urea excretion is a relevant marker for
IHD weaning that does not generate additional cost.
Third, we assessed weaning from IHD and not from
continuous RRT. IHD is widely used for RRT weaning
(and is the treatment of choice in our ICU) because it al-
lows early mobilization, which is now a major objective
in ICU patients. Daily urinary urea excretion could also
be used as a weaning marker for continuous RRT. The
measurement of daily urinary urea excretion requires
only urine collection and urinalysis and can therefore be
performed in ICU patients treated with continuous RRT.
Additional studies are needed to assess the threshold of
daily urinary urea excretion in continuous RRT. Finally,
daily urinary urea excretion is a marker that is related to
renal recovery and not the type of RRT.
Conclusions
To our knowledge, this study is the first to show an
association between renal recovery for IHD weaning
and both urine output and urinary urea concentration
in patients with AKI. Daily urinary urea excretion is
better than urine output alone for predicting IHD
weaning. A threshold of daily urinary urea excretion
greater than 1.35 mmol/kg/24 h was found to be the
best marker for weaning ICU patients with AKI from
IHD. Additional studies are needed to assess prospect-
ively the role of urinary markers in the strategy of RRT
weaning in ICU patients.
Key messages
 Urine output and urinary urea concentration are
both independently related to renal recovery for
intermittent hemodialysis weaning.
 Daily urinary urea excretion has a better
performance than urine output or urinary urea
concentration alone in identifying renal recovery for
intermittent hemodialysis weaning.
 Daily urinary urea excretion greater than
1.35 mmol/kg/24 h was found to be the best marker
for weaning ICU patients with AKI from
intermittent hemodialysis.
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